Cargando…

Treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series

BACKGROUND: Immune-compromised patients incur a high risk of surgical wound dehiscence and colonization by multidrug resistant organisms. Common treatment has been debridement and spontaneous secondary healing. We report on the results obtained in nine such patients whose wounds were treated by debr...

Descripción completa

Detalles Bibliográficos
Autores principales: Pignatti, Marco, Gerunda, Giorgio Enrico, Rompianesi, Gianluca, De Ruvo, Nicola, Di Benedetto, Fabrizio, Codeluppi, Mauro, Bonucchi, Decenzio, Pacchioni, Lucrezia, Loschi, Pietro, Malaventura, Cristina, De Santis, Giorgio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847491/
https://www.ncbi.nlm.nih.gov/pubmed/24139428
http://dx.doi.org/10.1186/1754-9493-7-28
_version_ 1782293611793088512
author Pignatti, Marco
Gerunda, Giorgio Enrico
Rompianesi, Gianluca
De Ruvo, Nicola
Di Benedetto, Fabrizio
Codeluppi, Mauro
Bonucchi, Decenzio
Pacchioni, Lucrezia
Loschi, Pietro
Malaventura, Cristina
De Santis, Giorgio
author_facet Pignatti, Marco
Gerunda, Giorgio Enrico
Rompianesi, Gianluca
De Ruvo, Nicola
Di Benedetto, Fabrizio
Codeluppi, Mauro
Bonucchi, Decenzio
Pacchioni, Lucrezia
Loschi, Pietro
Malaventura, Cristina
De Santis, Giorgio
author_sort Pignatti, Marco
collection PubMed
description BACKGROUND: Immune-compromised patients incur a high risk of surgical wound dehiscence and colonization by multidrug resistant organisms. Common treatment has been debridement and spontaneous secondary healing. We report on the results obtained in nine such patients whose wounds were treated by debridement, negative pressure dressing and direct closure. METHODS: All immune-compromised patients referred to our Institution between March 1, 2010 and November 30, 2011 for dehiscent abdominal wounds growing multidrug resistant organisms were treated by serial wound debridements and negative pressure dressing. They were primarily closed, despite positive microbiological cultures, when clinical appearance was satisfactory. As a comparison, records from patients treated between March 1, 2008 and February 28, 2010 who, according to our Institution’s policy at that time, had been left to heal by secondary intention, were retrieved and examined. RESULTS: Nine patients were treated by direct wound closure, five had been treated previously by secondary intention healing. Overall, ten patients had received liver transplant, 1 kidney transplant, 1 was HIV infected, 1 suffered from multi-organ failure, 1 was undergoing hemodialysis. Wound dehiscence involved skin and subcutaneous layers in all patients, in two the muscular layer was also involved. Mean healing time was significantly shorter in patients treated more recently by primary intention in comparison with historical patients (28 vs 81 days). The only complication observed was a small superficial abscess that developed around a non-absorbable stitch 10 months after closure in a patient treated by primary closure. CONCLUSIONS: According to our results, fast healing can be safely obtained by closure of a clinically healthy wound, despite growth of multidrug resistant organisms, even in immune-compromised patients.
format Online
Article
Text
id pubmed-3847491
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-38474912013-12-04 Treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series Pignatti, Marco Gerunda, Giorgio Enrico Rompianesi, Gianluca De Ruvo, Nicola Di Benedetto, Fabrizio Codeluppi, Mauro Bonucchi, Decenzio Pacchioni, Lucrezia Loschi, Pietro Malaventura, Cristina De Santis, Giorgio Patient Saf Surg Research BACKGROUND: Immune-compromised patients incur a high risk of surgical wound dehiscence and colonization by multidrug resistant organisms. Common treatment has been debridement and spontaneous secondary healing. We report on the results obtained in nine such patients whose wounds were treated by debridement, negative pressure dressing and direct closure. METHODS: All immune-compromised patients referred to our Institution between March 1, 2010 and November 30, 2011 for dehiscent abdominal wounds growing multidrug resistant organisms were treated by serial wound debridements and negative pressure dressing. They were primarily closed, despite positive microbiological cultures, when clinical appearance was satisfactory. As a comparison, records from patients treated between March 1, 2008 and February 28, 2010 who, according to our Institution’s policy at that time, had been left to heal by secondary intention, were retrieved and examined. RESULTS: Nine patients were treated by direct wound closure, five had been treated previously by secondary intention healing. Overall, ten patients had received liver transplant, 1 kidney transplant, 1 was HIV infected, 1 suffered from multi-organ failure, 1 was undergoing hemodialysis. Wound dehiscence involved skin and subcutaneous layers in all patients, in two the muscular layer was also involved. Mean healing time was significantly shorter in patients treated more recently by primary intention in comparison with historical patients (28 vs 81 days). The only complication observed was a small superficial abscess that developed around a non-absorbable stitch 10 months after closure in a patient treated by primary closure. CONCLUSIONS: According to our results, fast healing can be safely obtained by closure of a clinically healthy wound, despite growth of multidrug resistant organisms, even in immune-compromised patients. BioMed Central 2013-09-03 /pmc/articles/PMC3847491/ /pubmed/24139428 http://dx.doi.org/10.1186/1754-9493-7-28 Text en Copyright © 2013 Pignatti et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Pignatti, Marco
Gerunda, Giorgio Enrico
Rompianesi, Gianluca
De Ruvo, Nicola
Di Benedetto, Fabrizio
Codeluppi, Mauro
Bonucchi, Decenzio
Pacchioni, Lucrezia
Loschi, Pietro
Malaventura, Cristina
De Santis, Giorgio
Treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series
title Treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series
title_full Treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series
title_fullStr Treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series
title_full_unstemmed Treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series
title_short Treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series
title_sort treatment of wounds colonized by multidrug resistant organisms in immune-compromised patients: a retrospective case series
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847491/
https://www.ncbi.nlm.nih.gov/pubmed/24139428
http://dx.doi.org/10.1186/1754-9493-7-28
work_keys_str_mv AT pignattimarco treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT gerundagiorgioenrico treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT rompianesigianluca treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT deruvonicola treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT dibenedettofabrizio treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT codeluppimauro treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT bonucchidecenzio treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT pacchionilucrezia treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT loschipietro treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT malaventuracristina treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries
AT desantisgiorgio treatmentofwoundscolonizedbymultidrugresistantorganismsinimmunecompromisedpatientsaretrospectivecaseseries